Comparison of Serious Adverse Event Profiles Among Antirheumatic Agents Using Japanese Adverse Drug Event Report Database

被引：0
|
作者：
Yomei Matsuoka
Mamoru Narukawa
机构：
[1] Kitasato University,Department of Clinical Medicine (Pharmaceutical Medicine), Graduate School of Pharmaceutical Sciences
来源：
Therapeutic Innovation & Regulatory Science | 2018年 / 52卷
关键词：
JADER; serious adverse event; SAE; antirheumatic agent; reporting odds ratio; time to onset;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：339 / 347
页数：8
相关论文
共 50 条
  • [21] Analysis of Adverse Drug Reaction Risk in Elderly Patients Using the Japanese Adverse Drug Event Report (JADER) Database
    Chisaki, Yugo
    Aoji, Shoki
    Yano, Yoshitaka
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2017, 40 (06) : 824 - 829
  • [22] Analysis of drug adverse events in elderly patients based on the Japanese Adverse Drug Event Report Database
    Okada, Akira
    Sera, Shoji
    Taguchi, Maho
    Yamada, Hiroaki
    Nagai, Naomi
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2022, 47 (08) : 1264 - 1269
  • [23] Progressive multifocal leukoencephalopathy analyzed using the Japanese Adverse Drug Event Report database
    Sakurai, Shuji
    Maezawa, Mika
    Nakao, Satoshi
    Hirofuji, Sakiko
    Miyasaka, Koumi
    Yamashita, Moe
    Matsui, Kensuke
    Nishida, Shohei
    Kobayashi, Ryo
    Iguchi, Kazuhiro
    Hayashi, Yuichi
    Suzuki, Akio
    Nakamura, Mitsuhiro
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 455
  • [24] Disproportionality analysis of cardiac adverse events associated with lenvatinib using the Japanese Adverse Drug Event Report database
    Kanbayashi, Yuko
    Kobayashi, Sakura
    Kojima, Asuka
    Wakabayashi, Haruka
    Shimizu, Tadashi
    Uchida, Mayako
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 90 (12) : 3348 - 3354
  • [25] Visualization of Kinase Inhibition-Related Adverse Events Using the Japanese Adverse Drug Event Report Database
    Mizuno, Takahito
    Sakai, Takamasa
    Tanabe, Kouichi
    Umemura, Takumi
    Goto, Nobuyuki
    Ohtsu, Fumiko
    DRUGS-REAL WORLD OUTCOMES, 2021, 8 (02) : 197 - 206
  • [26] Visualization of Kinase Inhibition-Related Adverse Events Using the Japanese Adverse Drug Event Report Database
    Takahito Mizuno
    Takamasa Sakai
    Kouichi Tanabe
    Takumi Umemura
    Nobuyuki Goto
    Fumiko Ohtsu
    Drugs - Real World Outcomes, 2021, 8 : 197 - 206
  • [27] Analysis of fall-related adverse events among older adults using the Japanese Adverse Drug Event Report (JADER) database
    Haruna Hatahira
    Shiori Hasegawa
    Sayaka Sasaoka
    Yamato Kato
    Junko Abe
    Yumi Motooka
    Akiho Fukuda
    Misa Naganuma
    Satoshi Nakao
    Ririka Mukai
    Kazuyo Shimada
    Kouseki Hirade
    Takeshi Kato
    Mitsuhiro Nakamura
    Journal of Pharmaceutical Health Care and Sciences, 4 (1)
  • [28] Analysis of fall-related adverse events among older adults using the Japanese Adverse Drug Event Report (JADER) database
    Hatahira, Haruna
    Hasegawa, Shiori
    Sasaoka, Sayaka
    Kato, Yamato
    Abe, Junko
    Motooka, Yumi
    Fukuda, Akiho
    Naganuma, Misa
    Nakao, Satoshi
    Mukai, Ririka
    Shimada, Kazuyo
    Hirade, Kouseki
    Kato, Takeshi
    Nakamura, Mitsuhiro
    JOURNAL OF PHARMACEUTICAL HEALTH CARE AND SCIENCES, 2018, 4
  • [29] Categorisation of Pharmaceutical Adverse Events Using the Japanese Adverse Drug Event Report Database: Characteristic Adverse Drug Events of the Elderly Treated with Polypharmacy
    Negishi, Akio
    Oshima, Shinji
    Horii, Norimitsu
    Mutoh, Mizue
    Inoue, Naoko
    Numajiri, Sachihiko
    Ohshima, Shigeru
    Kobayashi, Daisuke
    DRUGS-REAL WORLD OUTCOMES, 2021, 8 (01) : 49 - 61
  • [30] Categorisation of Pharmaceutical Adverse Events Using the Japanese Adverse Drug Event Report Database: Characteristic Adverse Drug Events of the Elderly Treated with Polypharmacy
    Akio Negishi
    Shinji Oshima
    Norimitsu Horii
    Mizue Mutoh
    Naoko Inoue
    Sachihiko Numajiri
    Shigeru Ohshima
    Daisuke Kobayashi
    Drugs - Real World Outcomes, 2021, 8 : 49 - 61
12345